Disorder of multiple glycosylation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309526
Who is this for?
Show terms as
2Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of multiple glycosylation is a group of rare inherited metabolic conditions that affect a process called glycosylation. Glycosylation is the way your body attaches sugar molecules (called glycans) to proteins and fats. These sugar-coated molecules are essential for nearly every cell and organ in the body to work properly. When this process goes wrong in multiple ways at once, it can cause problems in many different organ systems, which is why these conditions are sometimes called congenital disorders of glycosylation (CDG) affecting multiple pathways. Because glycosylation is so important throughout the body, symptoms can be very wide-ranging. Common problems include developmental delay, intellectual disability, poor muscle tone (hypotonia), failure to thrive, liver problems, blood clotting issues, seizures, and skeletal abnormalities. Many affected children show signs from birth or early infancy. The severity varies greatly depending on the specific genetic cause, ranging from mild to life-threatening. There is currently no cure for most forms of this disorder. Treatment is mainly supportive and focuses on managing individual symptoms. For example, physical therapy can help with motor skills, anti-seizure medications may be used for epilepsy, and nutritional support can address feeding difficulties. In a small number of specific subtypes, targeted treatments such as mannose supplementation (for MPI-CDG) have shown benefit. Research into new therapies is ongoing, and early diagnosis through genetic testing is important to guide care and connect families with the right specialists.

Key symptoms:

Developmental delayIntellectual disabilityLow muscle tone (floppy baby)Failure to thrive or poor weight gainSeizures or epilepsyLiver problemsBlood clotting abnormalitiesAbnormal fat distributionInverted nipplesCrossed eyes (strabismus)Skeletal abnormalitiesHeart problemsImmune system weaknessFeeding difficultiesVision problems

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Apr 2026Oral N-acetylglucosamine in Crohn's Disease

Johns Hopkins University — PHASE2

TrialNOT YET RECRUITING
Oct 2019Clinical and Basic Investigations Into Congenital Disorders of Glycosylation

Icahn School of Medicine at Mount Sinai

TrialRECRUITING
Mar 2014Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation

National Human Genome Research Institute (NHGRI)

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Disorder of multiple glycosylation.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Other2 trials
Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
Actively Recruiting
PI: Eva Morava-Kozicz, MD, PhD (Icahn School of Medicine at Mount Sinai) · Sites: San Diego, California; Aurora, Colorado +10 more
Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
Actively Recruiting
PI: Lynne A Wolfe, C.R.N.P. (National Human Genome Research Institute (NHGRI)) · Sites: Bethesda, Maryland · Age: 080 yrs

No specialists are currently listed for Disorder of multiple glycosylation.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of multiple glycosylation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of multiple glycosylationForum →

No community posts yet. Be the first to share your experience with Disorder of multiple glycosylation.

Start the conversation →

Latest news about Disorder of multiple glycosylation

No recent news articles for Disorder of multiple glycosylation.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific subtype of congenital disorder of glycosylation does my child have, and what does that mean for their future?,Are there any targeted treatments available for our specific subtype?,What specialists should we see regularly, and how often?,What emergency situations should we watch for, and what should we do if they happen?,Are there any clinical trials or new research studies we could participate in?,What therapies (physical, occupational, speech) would benefit my child the most right now?,Should other family members be tested, and what are the chances of having another affected child?

Common questions about Disorder of multiple glycosylation

What is Disorder of multiple glycosylation?

Disorder of multiple glycosylation is a group of rare inherited metabolic conditions that affect a process called glycosylation. Glycosylation is the way your body attaches sugar molecules (called glycans) to proteins and fats. These sugar-coated molecules are essential for nearly every cell and organ in the body to work properly. When this process goes wrong in multiple ways at once, it can cause problems in many different organ systems, which is why these conditions are sometimes called congenital disorders of glycosylation (CDG) affecting multiple pathways. Because glycosylation is so impo

Are there clinical trials for Disorder of multiple glycosylation?

Yes — 2 recruiting clinical trials are currently listed for Disorder of multiple glycosylation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.